The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Paul A. Marks

Sloan-Kettering Institute

Memorial Sloan-Kettering Cancer Center

Cell Biology and Genetics Program

1275 York Ave

USA

[email]@mskcc.org

Name/email consistency: high

[Claim this account]

Affiliations

Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, Cell Biology and Genetics Program, 1275 York Ave, USA. 2005 - 2010
Memorial Sloan-Kettering Cancer Center, Cell Biology Program, Sloan-Kettering Institute for Cancer Research, New York City, USA. 2005

References

The clinical development of histone deacetylase inhibitors as targeted anticancer drugs. Marks, P.A. Expert. Opin. Investig. Drugs (2010) [Pubmed]
Histone deacetylase inhibitors: Potential in cancer therapy. Marks, P.A., Xu, W.S. J. Cell. Biochem. (2009) [Pubmed]
The American Society for Clinical Investigation--the first 100 years. Marks, P.A. J. Clin. Invest. (2008) [Pubmed]
Discovery and development of SAHA as an anticancer agent. Marks, P.A. Oncogene (2007) [Pubmed]
Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Marks, P.A., Breslow, R. Nat. Biotechnol. (2007) [Pubmed]
Histone deacetylase inhibitors in programmed cell death and cancer therapy. Marks, P.A., Jiang, X. Cell. Cycle (2005) [Pubmed]
Histone deacetylase inhibitors: discovery and development as anticancer agents. Marks, P.A., Dokmanovic, M. Expert. Opin. Investig. Drugs (2005) [Pubmed]